510(k) K213896
K213896 is an FDA 510(k) premarket notification submitted by Bard Peripheral Vascular for the device "BD Trek Powered Bone Biopsy System". The FDA issued a decision of Substantially Equivalent on Mar 30, 2022. The device falls under product code KNW (Instrument, Biopsy), a Class II device regulated under 21 CFR 876.1075. Bard Peripheral Vascular has 38 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 30, 2022
- Date Received
- Dec 14, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Instrument, Biopsy
- Device Class
- Class II
- Regulation Number
- 876.1075
- Review Panel
- SU
- Submission Type
- 510(k)
Need the full FDA record for Bard Peripheral Vascular? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.